NetEase is a cash-rich, hyper-efficient gaming compounder trading at a historically distressed valuation, offering an unparalleled margin of safety through aggressive buybacks, though investors must stomach the inherent volatility of its investment portfolio and domestic regulatory shifts.
Nordson is a highly profitable industrial tollbooth capitalizing on structural semiconductor and medical trends, though its premium valuation suggests patiently waiting for a broader margin of safety before initiating new positions.
National HealthCare is an elite, geographically concentrated post-acute compounder brilliantly internalizing its real estate to drive immense free cash flow, though investors must navigate the execution risks of its sudden shift from a debt-free operator to a leveraged owner at peak historical valuations.
National Health Investors offers a highly secure, well-covered dividend supported by a peerless deleveraged balance sheet, though near-term capital appreciation is moderately constrained by the execution risks of expanding its senior housing operating portfolio amid elevated labor costs.
Envista is executing a highly profitable, extraordinarily cash-generative turnaround fueled by market share gains in clear aligners, though its premium valuation requires investors to remain highly vigilant regarding the vulnerability of elective dentistry to consumer recessions.
Nelnet is an exceptional capital-compounding machine disguised as a boring student loan servicer, using massive cash flows from an amortizing legacy portfolio to fund highly profitable tech and banking ventures at a deep discount to its true sum-of-the-parts intrinsic value.
Novanta is a top-tier, oligopolistic provider of mission-critical medical and robotics technology that is rapidly compounding cash flows via brilliant M&A, though investors must currently exit the stock due to a severe valuation premium that leaves zero room for integration missteps.
Nu's profitable Latin American digital banking platform combines AI operating leverage with a $1B buyback, but early deterioration in unsecured-credit delinquency metrics warrants monitoring.
Nexstar is the undisputed, highly profitable tollbooth of local broadcast television, trading at an extremely cheap valuation with massive political advertising tailwinds, though investors must vigilantly monitor its heavy debt load and the ongoing antitrust injunction severely complicating the TEGNA integration.
NexGen offers the world's highest-grade, most scalable solution to the structural Western uranium deficit, though investors must absorb a grueling four-year execution timeline and multi-billion dollar capital expenditure cycle before the asset transforms into a cash-printing juggernaut.
NICE is the undisputed, highly profitable tollbooth of enterprise customer orchestration, trading at a deeply distressed valuation due to myopic fears of seat-license cannibalization, offering an immense margin of safety as it flawlessly transitions into the agentic AI consumption era.
New Jersey Resources operates a flawlessly managed, cash-generative regulated utility monopoly whose slow, steady rate-base growth is uniquely turbocharged by a highly profitable wholesale gas trading arm and a rapidly expanding solar portfolio.